Astria Therapeutics, Inc. Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2025-09-30..
Quick ratio
Overview →Financial period ending 2025-09-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2025-09-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 23.52M USD | Liabilities, Current |
| Cash and equivalents | 96.28M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 17.24M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2025-09-30 | (m) | $23.52M | $96.28M | (m) | $17.24M | (m) | (m) |
| 2025-06-30 | (m) | $18.04M | $76.32M | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | $17.43M | $54.38M | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | $19.13M | $59.82M | (m) | $0.00 | (m) | (m) |
| 2024-09-30 | (m) | $15.72M | $80.90M | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | $16.37M | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | $11.07M | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $11.55M | $175.53M | (m) | (m) | (m) | (m) |
| 2023-09-30 | (m) | $9.38M | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | $6.60M | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | $6.67M | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $9.06M | $20.52M | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | $6.44M | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | $5.22M | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | $4.97M | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $5.20M | $86.51M | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | $4.70M | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | $3.99M | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | $4.41M | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $6.39M | $24.93M | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | $6.98M | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | $5.51M | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | $4.59M | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | $5.03M | $9.90M | (m) | (m) | (m) | (m) |
| 2019-09-30 | (m) | $5.56M | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | $5.17M | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | $4.30M | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | $4.17M | $15.29M | (m) | (m) | (m) | (m) |
| 2018-09-30 | (m) | $4.13M | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | $4.96M | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | $5.28M | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | $6.02M | $16.37M | (m) | (m) | (m) | (m) |
| 2017-09-30 | (m) | $7.56M | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | $8.13M | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | $7.50M | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | $8.32M | $23.60M | (m) | (m) | (m) | (m) |
| 2016-09-30 | (m) | $8.54M | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | $7.42M | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | $7.43M | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | $7.78M | (m) | (m) | (m) | (m) | (m) |
| 2015-09-30 | (m) | $7.41M | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | $7.39M | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | (m) | $24.30M | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | $4.23M | (m) | (m) | (m) | (m) | (m) |
| 2014-09-30 | (m) | (m) | $15.68M | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | $20.85M | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | (m) | $30.47M | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | (m) | $5.43M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.